Evaluation of HIV-protease inhibitors as substrates and inhibitors of hepatic drug uptake transporters.

被引：0
|
作者：
Choo, EF [1 ]
Leake, B [1 ]
Wilkinson, GR [1 ]
Kim, RB [1 ]
机构：
[1] Vanderbilt Univ, Div Clin Pharmacol, Nashville, TN USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2001年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P22 / P22
页数：1
相关论文
共 50 条
  • [21] Quantitative structure-activity relationships of some HIV-protease inhibitors
    Gupta, SP
    Babu, MS
    Kaw, N
    JOURNAL OF ENZYME INHIBITION, 1999, 14 (02): : 109 - 123
  • [22] Synthesis and biological evaluation in vitro and in mammalian cells of new heteroaryl carboxyamides as HIV-protease inhibitors
    Funicello, M.
    Chiummiento, L.
    Tramutola, F.
    Armentano, M. F.
    Bisaccia, F.
    Miglionico, R.
    Milella, L.
    Benedetti, F.
    Berti, F.
    Lupattelli, P.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (17) : 4715 - 4722
  • [23] HIV protease inhibitors:: drug interactions
    Gérard, Y
    Maulin, L
    Dubreuil, L
    Mouton, Y
    REVUE DE MEDECINE INTERNE, 1999, 20 (02): : 141 - 150
  • [24] Drug Interactions of HIV Protease Inhibitors
    Lisa I. Malaty
    Jeffrey J. Kuper
    Drug Safety, 1999, 20 : 147 - 169
  • [25] Drug interactions with HIV protease inhibitors
    Boyle, B
    INFECTIONS IN MEDICINE, 1997, 14 : 17 - 18
  • [26] Lysine sulfonamides as novel HIV-protease inhibitors:: Nε-disubstituted ureas
    Stranix, BR
    Sauvé, G
    Bouzide, A
    Coté, A
    Sévigny, G
    Yelle, J
    Perron, V
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (15) : 3971 - 3974
  • [27] Drug interactions of HIV protease inhibitors
    Malaty, LI
    Kuper, JJ
    DRUG SAFETY, 1999, 20 (02) : 147 - 169
  • [28] Differentiation of atazanavir from other HIV-protease inhibitors in preclinical models of glucose uptake, lipogenesis and proteasome function
    Wang, S
    Mulvey, R
    Laing, N
    Leet, J
    Flint, O
    Parker, RA
    ANTIVIRAL THERAPY, 2002, 7 (03) : L6 - L7
  • [29] Clinical outcome after coronary events in patients treated with HIV-protease inhibitors
    Monsuez, JJ
    Gallet, B
    Escaut, L
    Vayre, F
    Charniot, JC
    Pulik, M
    Merad, M
    Minozzi, C
    Slama, M
    Weber, S
    Vittecoq, D
    EUROPEAN HEART JOURNAL, 2000, 21 (24) : 2079 - 2080
  • [30] A COMBINATORIAL APPROACH TO IDENTIFY NOVEL HIV-PROTEASE (WILD AND MUTANT) INHIBITORS (PIs) USING ZINC DRUG DATABASE
    Srivastava, K. K.
    Srivastava, Shubha
    Alam, Tanweer
    Rituraj
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2015, 6 (07): : 2926 - 2935
12345